| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 07/02/2003 | EP1323424A1 Buffalo milk gangliosides |
| 07/02/2003 | EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/02/2003 | EP1322302A2 Taxoid conjugates as antimitotic and antitumor agents |
| 07/02/2003 | EP1240177B1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/02/2003 | EP1165580B1 Catalytic method for modifying carbohydrates, alcohols, aldehydes or polyhydroxy compounds |
| 07/02/2003 | CN1427846A Uridine derivatives as antibiotics |
| 07/02/2003 | CN1113102C Antitumer preparation |
| 06/26/2003 | WO2003051889A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 06/26/2003 | WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same |
| 06/26/2003 | WO2003030820A3 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae |
| 06/26/2003 | US20030119902 Novel aminobenzoephenones |
| 06/26/2003 | US20030119724 Contain a hepatic ligand to direct an oligomer or "payload" to a hepatocyte intracellularly via a receptor-mediated, ligand-directed pathway; solid phase synthesis |
| 06/26/2003 | US20030119051 Saccharide library |
| 06/26/2003 | US20030115687 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres |
| 06/26/2003 | CA2469879A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 06/25/2003 | CN1426419A Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 06/24/2003 | US6583119 Aromatic antibiotics such as 7-((6-deoxy-5-methyl-4-methyl-hexopyranosyl)oxy)-4-hydroxy-8-methyl-3-(1 -(phenoxyimino) ethyl)-2H-1-benzopyran-2-one (2-propynyloxy)-carbamic 3'-ester acid, for prevention of grampositive bacterial infections |
| 06/24/2003 | US6581613 Alkylpolyglucoside with a high degree of oligomerization |
| 06/19/2003 | US20030114361 Antithrombotic compound |
| 06/19/2003 | US20030113769 Aminooxy functionalized oligomers, oligomer arrays and methods of using them |
| 06/18/2003 | EP1077984B1 2"-deoxy hygromycin derivatives |
| 06/18/2003 | EP1064291B1 Methods of synthesizing gm3 |
| 06/18/2003 | CN1425015A Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 06/18/2003 | CN1424318A Structure of phenethyl alcohol glycoside compound and its use |
| 06/17/2003 | US6579725 Linkers for synthesis of oligosaccharides on solid supports |
| 06/12/2003 | WO2003048375A1 Hybrid glycosylated products and their production and use |
| 06/12/2003 | WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 06/12/2003 | US20030109688 Purification using cationic ion exchange resins |
| 06/12/2003 | US20030109603 Epoxy resin and polyglycoside based polymers and process for the preparation thereof |
| 06/12/2003 | US20030109489 Oligosaccharide derivatives and process for producing the same |
| 06/12/2003 | US20030109461 Antimicrobial 2-deoxystreptamine compounds |
| 06/12/2003 | US20030108595 Prevent deposits of amyloid; using sulfonate or sulfate compound |
| 06/11/2003 | EP1317465A1 Purine derivatives |
| 06/11/2003 | EP1230251B1 Method for producing solid sugar surfactants |
| 06/10/2003 | US6576752 Aminooxy functionalized oligomers |
| 06/10/2003 | US6576259 Sustained release formulations containing tacrolimus |
| 06/10/2003 | CA2189603C Propiophenone derivative and processes for preparing the same |
| 06/05/2003 | WO2003008430A3 Porphyrin derivatives for photodynamic therapy |
| 06/05/2003 | US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments |
| 06/05/2003 | US20030105032 Administering compound selected from MonoPhosphoryl Lipid A (MPL) and Serinol Aminoalkyl Glucosaminide Phosphate compound (AGP) for prophylaxis and therapy of infectious disease, autoimmune disease or allergic condition |
| 06/05/2003 | US20030105028 Substituted 2-azetidinones useful as hypocholesterolemic agents |
| 06/05/2003 | US20030104007 Pseudopterosin compounds of Symbiodinium spp isolated from Pseudopterogorgia elisabethae |
| 06/05/2003 | US20030101989 Mixture of glucopyranoses |
| 06/04/2003 | EP1316558A1 Tetraphenylbacteriochlorin derivatives and compositions containing the same |
| 06/04/2003 | EP1007031B1 4-cyano-4-deformylsordarin derivatives |
| 06/04/2003 | EP0975648B1 Morphine derivatives |
| 06/04/2003 | EP0848752B1 Method for purifying viruses by chromatography |
| 06/04/2003 | CN1422263A Estrogen agonist/antagonist metabolites |
| 06/04/2003 | CN1421453A Structure and use of acanthus illicifolius glycoside B as one fatty alcohol glycoside compound |
| 06/03/2003 | US6573367 Derivatives from the class of oleandomycin |
| 06/03/2003 | US6573337 Dioxocyclohexane compound linker for solid-phase synthesis of oligosaccharides |
| 06/03/2003 | US6573248 Monocyclic L-nucleosides, analogs and uses thereof |
| 06/03/2003 | US6573246 Modified ether glyceroglycolipids |
| 05/30/2003 | WO2003044034A1 Heterodimeric conjugates of neomycin-chloramphenicol having an enhanced specificity against rna targets and its preparation |
| 05/30/2003 | WO2003044033A1 Novel immunosuppressants |
| 05/30/2003 | WO2003044032A1 Sugar derivative |
| 05/30/2003 | WO2003043656A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/30/2003 | WO2003043613A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 05/30/2003 | WO2002055490A3 Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 05/29/2003 | US20030100555 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 05/29/2003 | US20030100515 Benzophenone glycopyranosides, preparation and therapeutic use |
| 05/28/2003 | EP1313752A2 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 05/28/2003 | EP1313750A1 Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction |
| 05/28/2003 | EP1313377A2 Treatment of helicobacter with isothiocyanates |
| 05/28/2003 | EP1203002B1 Process for preparing a charcoal-gm1 complex |
| 05/28/2003 | EP1049706B1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same |
| 05/28/2003 | EP0966516B1 Method for producing neutral sugar surfactant granulates |
| 05/28/2003 | CN1420121A Mtehod for microwave extracting nimbin from nim kernel |
| 05/28/2003 | CN1420120A Medicinal preparation contg. 1-N-ethyl vistamycin or its salt, and process for preparing same |
| 05/28/2003 | CN1109682C Process for extracting soybean isoflavone and soybean glucoside |
| 05/27/2003 | US6569906 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase |
| 05/27/2003 | US6569835 Hypolipidemics; treating obesity and disorders of lipid metabolism |
| 05/27/2003 | US6569355 Chiral compounds, and their use as chiral dopants for the preparation of cholesteric liquid-crystalline compositions |
| 05/22/2003 | WO2002095393A3 Drug evolution: drug design at hot spots |
| 05/22/2003 | US20030096765 Aromatic esters; cytotoxic agents; antitumor agents |
| 05/21/2003 | EP1312347A1 Use of an extract of myrsine africana for the oxidative dyeing of keratinic fibres |
| 05/21/2003 | EP1311523A1 Method for the production of alkyl glucosides, especially alkyl fructosides |
| 05/21/2003 | EP1311522A1 New immunoeffector compounds |
| 05/21/2003 | EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations |
| 05/21/2003 | EP0835118B1 Utilization of sophorolipids for the preparation of cosmetic products, in particular for the treatment of the skin |
| 05/21/2003 | CN1419450A Nitrite salts of antimicrobial agents |
| 05/21/2003 | CN1419435A Skin preparations for extenal use |
| 05/21/2003 | CN1109042C Process for extracting theasaponin from tea cake by n-butyl alcohol |
| 05/21/2003 | CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof |
| 05/20/2003 | US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use |
| 05/20/2003 | CA2290004C Isoflavone rich protein isolate and process for producing |
| 05/20/2003 | CA2091668C Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles |
| 05/15/2003 | WO2003040127A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 05/15/2003 | WO2003040104A1 Dimeric pharmaceutical compounds and their use |
| 05/15/2003 | WO2003039231A2 Compounds and methods for treating transplant rejection |
| 05/15/2003 | US20030092643 Augment antibody production in immunized animals, and stimulate cytokine production and activate macrophages |
| 05/15/2003 | US20030092637 Novel compounds |
| 05/15/2003 | US20030092610 Culturing a glycopeptide antibiotic-producing strain of Streptomyces hygroscopicus under aerobic conditions and recovering the antibiotic; specific strains of microorganism; antibiotic is cyclic peptide with 2-iminoimidazolidine groups |
| 05/15/2003 | CA2464717A1 Compounds and methods for treating transplant rejection |
| 05/15/2003 | CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
| 05/14/2003 | EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation |
| 05/14/2003 | EP0794788B1 Hepatic-directed compounds and reagents for preparation thereof |
| 05/14/2003 | CN1418219A Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the prepararation of the derivatives |